Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Algos Pharmaceutical Corp.

Division of Endo International PLC
www.algos.com

Latest From Algos Pharmaceutical Corp.

New Drugs for Pain

Spectacular failures in stroke and neurodegenerative diseases have given drug developers a black eye, but along the way, the insights they've gleaned in neurobiology have revealed new targets for pain. Unfortunately, the targets keep moving.
BioPharmaceutical

Rx Market Caps–the Flip Side: From Public-to-Private Investment

This month, we compared valuations for those biotech companies which had both gone public in '95 or '96 and had, in 1998, completed a round of private financing. As the amounts of private money raised got larger, so too did market cap valuations. One major reason: the larger the valuation, the more investors are willing to invest.
BioPharmaceutical Business Strategies

Approaching Addiction

Recent insights into the basic mechanisms of substance addiction are invigorating a range of research efforts in industry, academia and especially government. But it's clearly a risky business.
BioPharmaceutical Consumer

Rates of Return in Biotech IPOs by Market Cap

Though the market for biotech IPOs has been largely dormant recently, we wondered how biotechs that received the highest market caps in recent IPOs fared against their smaller-cap counterparts on delivering rates of return to private investors.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Endo International PLC
  • Senior Management
  • John W Lyle, Pres. & CEO
    Gary A Anthony, CFO
    Frank S Caruso, PhD, EVP, R&D
    Terence S Novack, EVP, Sales & Mktg.
  • Contact Info
  • Algos Pharmaceutical Corp.
    Phone: (732) 938-5959
    1333 Campus Pkwy.
    Neptune, NJ 07753-6815
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register